Ranolazine inhibits NaV1.5-mediated breast cancer cell invasiveness and lung colonization.
Driffort V, Gillet L, Bon E, Marionneau-Lambot S, Oullier T, Joulin V, Collin C, Pagès JC, Jourdan ML, Chevalier S, Bougnoux P, Le Guennec JY, Besson P, Roger S.
Driffort V, et al. Among authors: chevalier s.
Mol Cancer. 2014 Dec 11;13:264. doi: 10.1186/1476-4598-13-264.
Mol Cancer. 2014.
PMID: 25496128
Free PMC article.